These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30789540)

  • 61. Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients.
    Reese ES; Onukwugha E; Hanna N; Seal BS; Mullins CD
    Cancer Med; 2013 Dec; 2(6):907-15. PubMed ID: 24403264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
    André T; Meyerhardt J; Iveson T; Sobrero A; Yoshino T; Souglakos I; Grothey A; Niedzwiecki D; Saunders M; Labianca R; Yamanaka T; Boukovinas I; Vernerey D; Meyers J; Harkin A; Torri V; Oki E; Georgoulias V; Taieb J; Shields A; Shi Q
    Lancet Oncol; 2020 Dec; 21(12):1620-1629. PubMed ID: 33271092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
    Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
    Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.
    Lund JL; Sturmer T; Sanoff HK
    J Geriatr Oncol; 2016 May; 7(3):176-86. PubMed ID: 26926829
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer.
    Davidoff AJ; Tang M; Seal B; Edelman MJ
    J Clin Oncol; 2010 May; 28(13):2191-7. PubMed ID: 20351329
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
    Sobrero A; Lonardi S; Rosati G; Di Bartolomeo M; Ronzoni M; Pella N; Scartozzi M; Banzi M; Zampino MG; Pasini F; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Zagonel V; Maiello E; Barni S; Rulli E; Labianca R;
    J Clin Oncol; 2018 May; 36(15):1478-1485. PubMed ID: 29620994
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
    Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
    Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database.
    Cheung WY; Shi Q; O'Connell M; Cassidy J; Blanke CD; Kerr DJ; Meyers J; Van Cutsem E; Alberts SR; Yothers G; Sargent DJ;
    Clin Colorectal Cancer; 2013 Sep; 12(3):179-87. PubMed ID: 23810482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients.
    Woldemichael A; Onukwugha E; Seal B; Hanna N; Mullins CD
    J Manag Care Spec Pharm; 2016 Jun; 22(6):628-39. PubMed ID: 27231791
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data.
    Weiss JM; Pfau PR; O'Connor ES; King J; LoConte N; Kennedy G; Smith MA
    J Clin Oncol; 2011 Nov; 29(33):4401-9. PubMed ID: 21969498
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer.
    Abrams TA; Brightly R; Mao J; Kirkner G; Meyerhardt JA; Schrag D; Fuchs CS
    J Clin Oncol; 2011 Aug; 29(24):3255-62. PubMed ID: 21768462
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry.
    Park YS; Ji J; Zalcberg JR; El-Serafi M; Buzaid A; Ghosn M
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):334-42. PubMed ID: 26471890
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.
    Griffiths RI; Barron RL; Gleeson ML; Danese MD; O'Hagan A; Chia VM; Legg JC; Lyman GH
    Pharmacoeconomics; 2012 Feb; 30(2):103-18. PubMed ID: 21967155
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.
    Alberts SR; Sargent DJ; Nair S; Mahoney MR; Mooney M; Thibodeau SN; Smyrk TC; Sinicrope FA; Chan E; Gill S; Kahlenberg MS; Shields AF; Quesenberry JT; Webb TA; Farr GH; Pockaj BA; Grothey A; Goldberg RM
    JAMA; 2012 Apr; 307(13):1383-93. PubMed ID: 22474202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characteristics Associated With Nonreceipt of Surveillance Testing and the Relationship With Survival in Stage II and III Colon Cancer.
    Hines RB; Jiban MJH; Lee E; Odahowski CL; Wallace AS; Adams SJE; Rahman SMM; Zhang S
    Am J Epidemiol; 2021 Feb; 190(2):239-250. PubMed ID: 32902633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surveillance Colonoscopy in Older Stage I Colon Cancer Patients and the Association With Colon Cancer-Specific Mortality.
    Hines RB; Jiban MJH; Specogna AV; Vishnubhotla P; Lee E; Troy SP; Zhang S
    Am J Gastroenterol; 2020 Jun; 115(6):924-933. PubMed ID: 32142485
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
    Lonardi S; Sobrero A; Rosati G; Di Bartolomeo M; Ronzoni M; Aprile G; Massida B; Scartozzi M; Banzi M; Zampino MG; Pasini F; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Barni S; Zagonel V; Maiello E; Rulli E; Labianca R;
    Ann Oncol; 2016 Nov; 27(11):2074-2081. PubMed ID: 27573560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.